Ringpu Bio-Technology announces new leadership, board reorganization

Tianjin Ringpu Bio-Technology held its first extraordinary meeting of the sixth board of directors on December 15, 2025, following a shareholder and employee representative meeting. Li Shoujun was elected as chairman for a three-year term, and Xu Lei was appointed as general manager. Liu Ailing and Zhu Xiutong were named deputy general managers, Li Gaibian as chief financial officer, and Xie Gang as board secretary. Zhao Wenfu was appointed as securities affairs representative.

The board also established its specialized committees. The strategic committee will be chaired by Li Shoujun, the nomination committee by Dong Yichun, the audit committee by Li Ya, and the remuneration and assessment committee by Wang Kai. These committee members and senior management will serve three-year terms.

The previous board members, including independent directors Cai Xuesen and Guo Chunlin, and director Yang Que, will no longer hold their respective positions. Former supervisor Zhou Zhonghua, Liang Fei, and He Xinyang have also departed. Additionally, You Yongjun has transitioned from his senior management role to head of the marketing department.